Tag Archives: Data protection

INFORMED CONSENT – 5 CRITICAL ELEMENTS TO MONITOR

Ensuring proper informed consent in clinical studies is a critical process, that protects the rights, safety, and welfare of human subjects involved. It will require even more attention under the new GDPR and with the globalization of clinical trials. Although … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , | 1 Comment

EU MEDICAL DEVICE CLINICAL EVIDENCE 2016/2017

The year 2016 has been a very interesting one from clinical perspective with many developments in the EU medical device regulatory environment, and I am sure we are facing an even more interesting one coming up: The latest draft of … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , | Leave a comment

GENERAL DATA PROTECTION REGULATION – 5 CLINICAL ASPECTS

As mentioned in my previous post on the MEDDEV 2.7/1 revision 4, the second quarter of 2016 is characterized by several big steps from clinical evidence perspective: Besides the publication of the new version of the MEDDEV 2.7/1, consensus was … Continue reading

Posted in Uncategorized | Tagged , , , , , | 2 Comments

EU MEDICAL DEVICE STUDIES IN 2015: A YEAR OF CONTRAST?

Happy New Year! Indeed the year 2015 did become an interesting one looking at it from an EU medical device study perspective. Especially since some of the events seem to create areas for tension: More transparency on clinical data, but … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , | Leave a comment

TRANSPARENCY IN MEDICAL DEVICE CLINICAL STUDIES – THE FUTURE IS NOW

The era of full clinical data transparency is here, and that includes medical devices: EMA issued their policy on the publication of clinical data effective as of the beginning of this year, and is currently requesting feedback on the application … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , | 2 Comments